VANGUARD GROUP INC - COHERUS BIOSCIENCES INC ownership

COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 115 filers reported holding COHERUS BIOSCIENCES INC in Q1 2017. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of COHERUS BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$36,585,157
-3.2%
9,782,127
+10.5%
0.00%0.0%
Q2 2023$37,788,010
-5.7%
8,849,651
+51.1%
0.00%0.0%
Q1 2023$40,063,248
-13.0%
5,857,200
+0.7%
0.00%0.0%
Q4 2022$46,061,785
-8.3%
5,815,882
+11.2%
0.00%0.0%
Q3 2022$50,248,000
+42.1%
5,228,701
+7.1%
0.00%0.0%
Q2 2022$35,355,000
-42.2%
4,883,415
+3.1%
0.00%0.0%
Q1 2022$61,156,000
-15.7%
4,737,101
+4.2%
0.00%
-50.0%
Q4 2021$72,579,000
+0.0%
4,547,529
+0.7%
0.00%0.0%
Q3 2021$72,545,000
+17.2%
4,514,301
+0.9%
0.00%0.0%
Q2 2021$61,897,000
-0.6%
4,475,604
+5.0%
0.00%0.0%
Q1 2021$62,256,000
-13.2%
4,261,100
+3.2%
0.00%0.0%
Q4 2020$71,761,000
+1.2%
4,128,935
+6.8%
0.00%0.0%
Q3 2020$70,913,000
+4.8%
3,866,529
+2.0%
0.00%0.0%
Q2 2020$67,690,000
+33.5%
3,790,062
+21.2%
0.00%0.0%
Q1 2020$50,714,000
-8.5%
3,126,609
+1.6%
0.00%0.0%
Q4 2019$55,432,000
-6.6%
3,078,703
+5.1%
0.00%0.0%
Q3 2019$59,330,000
-9.3%
2,928,394
-1.0%
0.00%0.0%
Q2 2019$65,384,000
+66.9%
2,958,583
+3.0%
0.00%0.0%
Q1 2019$39,167,000
+56.5%
2,871,492
+3.8%
0.00%
+100.0%
Q4 2018$25,034,000
-43.4%
2,766,112
+3.1%
0.00%
-50.0%
Q3 2018$44,266,000
+38.9%
2,682,801
+17.9%
0.00%
+100.0%
Q2 2018$31,868,000
+39.8%
2,276,281
+10.4%
0.00%0.0%
Q1 2018$22,791,000
+37.7%
2,062,522
+9.7%
0.00%0.0%
Q4 2017$16,547,000
-49.8%
1,880,448
-23.8%
0.00%
-50.0%
Q3 2017$32,943,000
+1.8%
2,467,566
+9.4%
0.00%0.0%
Q2 2017$32,367,000
-30.7%
2,255,467
+2.1%
0.00%0.0%
Q1 2017$46,726,000
+41.9%
2,209,244
+88.8%
0.00%0.0%
Q4 2016$32,932,000
+19.4%
1,169,842
+13.6%
0.00%0.0%
Q3 2016$27,575,000
+61.9%
1,029,701
+2.1%
0.00%
+100.0%
Q2 2016$17,030,000
+22.2%
1,008,298
+53.7%
0.00%0.0%
Q1 2016$13,931,000
-1.4%
656,195
+6.6%
0.00%0.0%
Q4 2015$14,135,000
-94.7%
615,619
-92.2%
0.00%
-90.0%
Q3 2015$265,655,000
+1635.5%
7,880,625
+1387.9%
0.01%
+900.0%
Q2 2015$15,307,000
+185.2%
529,657
+201.7%
0.00%
Q1 2015$5,368,000
+359.2%
175,543
+144.9%
0.00%
Q4 2014$1,169,00071,6820.00%
Other shareholders
COHERUS BIOSCIENCES INC shareholders Q1 2017
NameSharesValueWeighting ↓
CM Management, LLC 200,000$1,448,0001.54%
Tri Locum Partners LP 376,486$2,726,0001.12%
Perceptive Advisors 3,645,471$26,393,0000.83%
TANG CAPITAL MANAGEMENT LLC 750,000$5,430,0000.82%
Bridge City Capital, LLC 162,146$1,174,0000.62%
Knott David M Jr 186,134$1,348,0000.57%
Aristotle Capital Boston, LLC 2,322,168$16,812,0000.50%
Phocas Financial Corp. 316,455$2,291,0000.34%
Kohlberg Kravis Roberts & Co. L.P. 3,036,076$22,644,0000.30%
Temasek Holdings (Private) Ltd 7,381,116$53,439,2800.29%
View complete list of COHERUS BIOSCIENCES INC shareholders